Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea

Sang Hoon Ahn; Do Young Kim; Hye Young Chang; Sun Pyo Hong; Jeon Soo Shin; Yu Seun Kim; Hyejin Kim; Ja Kyung Kim; Yong Han Paik; Kwan Sik Lee; Chae Yoon Chon; Young Myoung Moon; Kwang Hyub Han

doi:10.1002/jmv.20739

Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea

Sang Hoon Ahn, Do Young Kim, Hye Young Chang, Sun Pyo Hong, Jeon Soo Shin, Yu Seun Kim, Hyejin Kim, Ja Kyung Kim, Yong Han Paik, Kwan Sik Lee, Chae Yoon Chon, Young Myoung Moon, Kwang Hyub Han

Research output: Contribution to journal › Article › peer-review

37 Citations (Scopus)

Abstract

Immunogenetic factors may play a role in determining the susceptibility of an individual to viral infection. The aim of current study was to investigate the association of clearance of hepatitis B virus (HBV) with promoter polymorphisms within the CC chemokine receptor 5 (CCR5) and its major ligand, regulated upon activation, normal T cells expressed and secreted (RANTES) genes. Five chemokine system polymorphisms (CCR5 Δ32, CCR5 promoter 59029G/A, 59353C/T, RANTES -403G/A, and -28C/G) were studied in a total of 698 subjects. The carriage of each genetic variant was compared among "spontaneously recovered" group (n = 243), "chronic carrier" group (n = 349), and "unexposed" group (n = 106). CCR5 59029G promoter variant was associated with clearance of HBV infection in an acute phase (OR = 1.71, P = 0.006, dominant model; OR = 2.17, P< 0.001, recessive model) and amelioration of hepatic inflammation (P = 0.003) with the control of HBV replication (P = 0.04) in chronic carriers. Interestingly, CCR5 59029 was linked completely to CCR5 59353, and CCR5 Δ32 homozygosity or heterozygosity was not found in any Korean patient. No association was seen with RANTES polymorphisms at position -403 and -28. The CCR5 59029G/CCR5 59353T polymorphism may play a role in the clearance of HBV infection.

Original language	English
Pages (from-to)	1564-1571
Number of pages	8
Journal	Journal of Medical Virology
Volume	78
Issue number	12
DOIs	https://doi.org/10.1002/jmv.20739
Publication status	Published - 2006 Dec

All Science Journal Classification (ASJC) codes

Virology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/jmv.20739

Cite this

@article{ef6c13e460e24f96af431e95ab52a0d0,

title = "Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea",

abstract = "Immunogenetic factors may play a role in determining the susceptibility of an individual to viral infection. The aim of current study was to investigate the association of clearance of hepatitis B virus (HBV) with promoter polymorphisms within the CC chemokine receptor 5 (CCR5) and its major ligand, regulated upon activation, normal T cells expressed and secreted (RANTES) genes. Five chemokine system polymorphisms (CCR5 Δ32, CCR5 promoter 59029G/A, 59353C/T, RANTES -403G/A, and -28C/G) were studied in a total of 698 subjects. The carriage of each genetic variant was compared among {"}spontaneously recovered{"} group (n = 243), {"}chronic carrier{"} group (n = 349), and {"}unexposed{"} group (n = 106). CCR5 59029G promoter variant was associated with clearance of HBV infection in an acute phase (OR = 1.71, P = 0.006, dominant model; OR = 2.17, P< 0.001, recessive model) and amelioration of hepatic inflammation (P = 0.003) with the control of HBV replication (P = 0.04) in chronic carriers. Interestingly, CCR5 59029 was linked completely to CCR5 59353, and CCR5 Δ32 homozygosity or heterozygosity was not found in any Korean patient. No association was seen with RANTES polymorphisms at position -403 and -28. The CCR5 59029G/CCR5 59353T polymorphism may play a role in the clearance of HBV infection.",

author = "Ahn, {Sang Hoon} and Kim, {Do Young} and Chang, {Hye Young} and Hong, {Sun Pyo} and Shin, {Jeon Soo} and Kim, {Yu Seun} and Hyejin Kim and Kim, {Ja Kyung} and Paik, {Yong Han} and Lee, {Kwan Sik} and Chon, {Chae Yoon} and Moon, {Young Myoung} and Han, {Kwang Hyub}",

year = "2006",

month = dec,

doi = "10.1002/jmv.20739",

language = "English",

volume = "78",

pages = "1564--1571",

journal = "Journal of Medical Virology",

issn = "0146-6615",

publisher = "Wiley-Liss Inc.",

number = "12",

}

TY - JOUR

T1 - Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea

AU - Ahn, Sang Hoon

AU - Kim, Do Young

AU - Chang, Hye Young

AU - Hong, Sun Pyo

AU - Shin, Jeon Soo

AU - Kim, Yu Seun

AU - Kim, Hyejin

AU - Kim, Ja Kyung

AU - Paik, Yong Han

AU - Lee, Kwan Sik

AU - Chon, Chae Yoon

AU - Moon, Young Myoung

AU - Han, Kwang Hyub

PY - 2006/12

Y1 - 2006/12

N2 - Immunogenetic factors may play a role in determining the susceptibility of an individual to viral infection. The aim of current study was to investigate the association of clearance of hepatitis B virus (HBV) with promoter polymorphisms within the CC chemokine receptor 5 (CCR5) and its major ligand, regulated upon activation, normal T cells expressed and secreted (RANTES) genes. Five chemokine system polymorphisms (CCR5 Δ32, CCR5 promoter 59029G/A, 59353C/T, RANTES -403G/A, and -28C/G) were studied in a total of 698 subjects. The carriage of each genetic variant was compared among "spontaneously recovered" group (n = 243), "chronic carrier" group (n = 349), and "unexposed" group (n = 106). CCR5 59029G promoter variant was associated with clearance of HBV infection in an acute phase (OR = 1.71, P = 0.006, dominant model; OR = 2.17, P< 0.001, recessive model) and amelioration of hepatic inflammation (P = 0.003) with the control of HBV replication (P = 0.04) in chronic carriers. Interestingly, CCR5 59029 was linked completely to CCR5 59353, and CCR5 Δ32 homozygosity or heterozygosity was not found in any Korean patient. No association was seen with RANTES polymorphisms at position -403 and -28. The CCR5 59029G/CCR5 59353T polymorphism may play a role in the clearance of HBV infection.

AB - Immunogenetic factors may play a role in determining the susceptibility of an individual to viral infection. The aim of current study was to investigate the association of clearance of hepatitis B virus (HBV) with promoter polymorphisms within the CC chemokine receptor 5 (CCR5) and its major ligand, regulated upon activation, normal T cells expressed and secreted (RANTES) genes. Five chemokine system polymorphisms (CCR5 Δ32, CCR5 promoter 59029G/A, 59353C/T, RANTES -403G/A, and -28C/G) were studied in a total of 698 subjects. The carriage of each genetic variant was compared among "spontaneously recovered" group (n = 243), "chronic carrier" group (n = 349), and "unexposed" group (n = 106). CCR5 59029G promoter variant was associated with clearance of HBV infection in an acute phase (OR = 1.71, P = 0.006, dominant model; OR = 2.17, P< 0.001, recessive model) and amelioration of hepatic inflammation (P = 0.003) with the control of HBV replication (P = 0.04) in chronic carriers. Interestingly, CCR5 59029 was linked completely to CCR5 59353, and CCR5 Δ32 homozygosity or heterozygosity was not found in any Korean patient. No association was seen with RANTES polymorphisms at position -403 and -28. The CCR5 59029G/CCR5 59353T polymorphism may play a role in the clearance of HBV infection.

UR - http://www.scopus.com/inward/record.url?scp=33750571393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750571393&partnerID=8YFLogxK

U2 - 10.1002/jmv.20739

DO - 10.1002/jmv.20739

M3 - Article

C2 - 17063508

AN - SCOPUS:33750571393

SN - 0146-6615

VL - 78

SP - 1564

EP - 1571

JO - Journal of Medical Virology

JF - Journal of Medical Virology

IS - 12

ER -

Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this